Granules India Ltd’s Mixed Week: -0.42% Price Change Amid Valuation and Technical Shifts

37 minutes ago
share
Share Via
Granules India Ltd closed the week marginally lower by 0.42% at ₹871.35, slightly outperforming the Sensex which declined 0.76%. The stock experienced a volatile week marked by valuation shifts, a rating upgrade, and a nuanced technical momentum transition. Despite the dip, Granules India’s robust financial performance and strong relative returns continue to underpin investor interest amid mixed short-term technical signals.

Key Events This Week

21 Sep: Valuation shifts to very expensive amid strong market returns

22 Sep: MarketsMOJO upgrades rating to Buy on fundamentals and technicals

25 Sep: Technical momentum shifts amid mixed indicator signals

Week Close: Stock ends at ₹871.35, down 0.42%; Sensex down 0.76%

Week Open
Rs.875.00
Week Close
Rs.871.35
-0.42%
Week High
Rs.875.45
vs Sensex
+0.34%

21 September 2026: Valuation Shifts to Very Expensive Amid Strong Returns

Granules India began the week with a slight gain, closing at ₹875.45, up 0.05% on the day, while the Sensex rose 0.46%. This modest uptick came alongside a significant valuation reassessment. The company’s price-to-earnings ratio surged to 36.71, categorising it as very expensive relative to historical averages and peers. The price-to-book value ratio also climbed to 4.69, signalling elevated price levels.

Enterprise value multiples such as EV/EBIT and EV/EBITDA stood at 25.18 and 19.13 respectively, reinforcing the premium valuation. Despite these stretched multiples, Granules India’s operational metrics remained strong, with a return on capital employed of 15.74% and return on equity of 11.86%. The stock’s year-to-date return of 46.19% starkly contrasted with the Sensex’s negative 12.82%, highlighting its outperformance.

However, MarketsMOJO downgraded the mojo grade to Hold on 16 September, reflecting caution due to the high valuation despite robust fundamentals. The downgrade underscored the risk of limited upside given the premium pricing, especially for a small-cap stock prone to volatility.

Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!

  • - Highest rated stock selection
  • - Multi-parameter screening cleared
  • - Large Cap quality pick

View Our Top 1% Pick →

22 September 2026: Upgrade to Buy on Strong Fundamentals and Technicals

The following day, MarketsMOJO upgraded Granules India’s rating from Hold to Buy, reflecting improved technical indicators and robust financial trends. The stock declined 1.25% to ₹864.50, underperforming the Sensex which fell 0.32%. Despite the price drop, the upgrade highlighted confidence in the company’s operational performance and market momentum.

Technical indicators showed a bullish medium-term outlook, with monthly MACD and Bollinger Bands signalling strength, although weekly MACD remained mildly bearish. The price-to-earnings ratio edged slightly higher to 36.87, confirming the very expensive valuation status. Other metrics such as price-to-book value of 4.71 and EV/EBITDA of 19.20 supported the premium pricing.

Financially, Granules India demonstrated strong growth with net sales for six months at ₹2,947.38 crores, up 22.42% year-on-year, and profit after tax rising 41.39% to ₹369.30 crores. Operational efficiency was evident with an operating profit to interest ratio of 16.05 times and a debt to EBITDA ratio of 1.28 times. Institutional investors increased holdings to 33.61%, signalling confidence.

The stock’s one-year return of 61.22% dwarfed the Sensex’s 9.40% decline, underscoring consistent outperformance. However, the modest five-year operating profit growth of 6.31% suggested tempered long-term growth prospects despite the upgrade.

23-24 September 2026: Price Consolidation Amid Mixed Market Conditions

On 23 September, Granules India’s stock declined further by 0.52% to ₹860.00, while the Sensex gained 0.56%. The following day, the stock fell 0.76% to ₹853.50, underperforming the Sensex’s sharp 1.62% decline. These movements reflected a consolidation phase amid volatile market conditions and mixed technical signals.

Volume was notably lower on 24 September at 11,162 shares, indicating reduced trading interest during the pullback. The stock remained well above its 52-week low of ₹511.00 but below the 52-week high of ₹922.10, suggesting a trading range with potential for both upside and downside volatility.

Want to dive deeper on Granules India Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!

  • - Real-time research report
  • - Complete fundamental analysis
  • - Peer comparison included

Read the Full Verdict →

25 September 2026: Technical Momentum Shifts Amid Mixed Indicator Signals

Granules India closed the week on a positive note, rising 2.09% to ₹871.35, outperforming the Sensex’s 0.18% gain. However, technical momentum showed signs of moderation. The daily moving averages remained mildly bullish, but the weekly MACD turned mildly bearish, indicating short-term momentum weakening. Conversely, the monthly MACD and Bollinger Bands stayed bullish, suggesting a sustained longer-term uptrend.

The Relative Strength Index hovered in neutral territory on weekly and monthly charts, implying no extreme overbought or oversold conditions. The Know Sure Thing (KST) oscillator presented a mixed picture, mildly bearish weekly but bullish monthly. Volume-based On-Balance Volume (OBV) and Dow Theory indicators echoed this divergence, with no clear weekly trend but bullish monthly signals.

This technical complexity points to a consolidation phase with a mildly bullish bias. Investors should be alert to potential short-term volatility while recognising the underlying strength in the stock’s medium-term trajectory.

Weekly Price Performance Comparison

Date Stock Price Day Change Sensex Day Change
2026-09-21 Rs.875.45 +0.05% 35,787.64 +0.46%
2026-09-22 Rs.864.50 -1.25% 35,672.04 -0.32%
2026-09-23 Rs.860.00 -0.52% 35,870.78 +0.56%
2026-09-24 Rs.853.50 -0.76% 35,291.38 -1.62%
2026-09-25 Rs.871.35 +2.09% 35,353.29 +0.18%

Key Takeaways

Positive Signals: Granules India continues to demonstrate strong financial performance with robust sales and profit growth, operational efficiency, and healthy returns on capital. The recent upgrade to Buy by MarketsMOJO reflects confidence in the company’s fundamentals and medium-term technical momentum. The stock’s consistent outperformance against the Sensex over multiple time horizons highlights its resilience and growth trajectory.

Cautionary Signals: The stock trades at a very expensive valuation with a P/E ratio near 37 and a PEG ratio above 1.7, indicating stretched price levels relative to earnings growth. Technical indicators reveal mixed momentum, with short-term signals showing mild bearishness and consolidation, suggesting potential volatility ahead. The modest five-year operating profit growth rate of 6.31% tempers expectations for sustained rapid expansion.

Investors should monitor key support levels near ₹850 and resistance around ₹870 to ₹922 to gauge trend sustainability. The interplay of valuation, fundamentals, and technicals suggests a cautious but constructive outlook for Granules India in the near term.

Conclusion

Granules India Ltd’s week was characterised by a delicate balance between strong fundamentals and mixed technical momentum. While the stock ended slightly lower by 0.42%, it outperformed the broader market’s 0.76% decline, underscoring its relative strength. The valuation remains very expensive, reflecting high investor expectations amid solid financial results and institutional backing.

The upgrade to a Buy rating by MarketsMOJO signals renewed confidence, supported by bullish monthly technical indicators and consistent market outperformance. However, short-term momentum indicators suggest a phase of consolidation and potential volatility, warranting a measured approach.

Overall, Granules India remains a key player in the Pharmaceuticals & Biotechnology sector with a strong growth record, but investors should weigh the premium valuation and mixed technical signals carefully when considering exposure.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News